J. L. Selam

Insulin detemir used in basal‐bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

I. De Leeuw, P Vague, J. L. Selam et al. · Diabetes Obesity and Metabolism · 2004 · 179 citations

Medicine, Endocrinology, Internal Medicine +16

Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus

A. J. M. Boulton, J. L. Selam, M.T. Sweeney et al. · Diabetologia · 2001 · 160 citations · Full text

Medicine, Pharmacotherapy, Urology +10

Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas

J Mirouze, J. L. Selam, T. C. Pham et al. · Diabetologia · 1978 · 130 citations · Full text

Medicine, Endocrinology, Pediatrics +12

The usage of a simplified self‐titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes – results of the randomized, controlled PREDICTIVE™ 303 study

Luigi Meneghini, Christoph Koenen, Wayne Weng et al. · Diabetes Obesity and Metabolism · 2007 · 127 citations

Medicine, Endocrinology, Internal Medicine +17

Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes

J Mirouze, J. L. Selam, T. C. Pham et al. · Diabetologia · 1977 · 85 citations · Full text

Medicine, Endocrinology, Internal Medicine +15